Telechem International 代理
简要描述：echem International代理，echem International上海代理， echem International代理, echem International代理上海金畔生物科技有限公司 echem International专业代理，具体产品信息欢迎电询：021-50837765
详细介绍
产品咨询
世界*实验材料供应商 echem International正式上海金畔为其中国代理， echem International在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔一直秉承为中国科研客户带来的产品，的服务， echem International就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获
echem International中国代理, echem International上海代理， echem International北京代理，echem International广东代理， echem International江苏代理echem International湖北代理,echem International天津,echem International黑龙江代理,echem International内蒙古代理,echem International吉林代理,echem International福建代理, echem International江苏代理, echem International浙江代理, echem International四川代理,
美国eChem International,Inc. www.arrayit.com
美国eChem International,Inc. 成立于1993年.
Our Philosophy
Our philosophy dictates the use of a highly skilled, multi-disciplinary team that places quality, customer service and price as the highest priorities for our products and services. Our innovative products and services empower our customers with immediate strategic advantage and consistent return on investment in the Life Sciences, Chemicals and Diagnostics industries.
Operations and History
eChem International, Inc., was founded in 1993 by Rene' Schena and Todd Martinsky as a chemical import and export trading company. eChem’s Chemicals Division continues to expand and diversify, providing customers with the raw materials required for plastics, water soluble fertilizers, and alternative fuels. After four years of solid success in the chemicals market, we expanded into the biotechnology sector and created the ArrayIt® Life Sciences Division in 1996. With the fervor over the Human Genome Project and the rise of microarray technology, we anticipated a demand for microarray products and services for the genetic, research, pharmaceutical and diagnostics markets. eChem’s ArrayIt® Division currently provides its patented microarray platform (US 6,101,946) to more than 3,000 installations serving an estimated 10,000 laboratories, making it the most widely used microarray technology in the world. Supporting instruments, kits, reagents, and hardware complete the ArrayIt® line of more than 400 products making up what is considered a universal microarray platform for all applications.
Building on the successes of the Chemicals and ArrayIt® Divisions, we started a Diagnostics Division to leverage our patented (6,913,879) multi-patient technology for genetic screening and testing. Next Generation Screening technology allows clinical laboratories to examine tens of thousands of patients on a single microarray, providing much more cost-effective gene information for population-wide diagnostics than traditional “single patient” microarrays. We are currently developing or have developed tests for many major human diseases including cystic fibrosis, sickle cell anemia, and cancer. Arrayit Diagnostics is well positioned to compete in the $20 billion molecular diagnostics arena. Patents issued and pending worldwide, contact us for licensing this technology in your area.
Having just celebrated our 15th anniversary, we are pleased to announce that our customer base includes every major university, pharmaceutical and biotech company, agricultural and chemical company, government agency, national research foundation and private sector enterprise in the world. Our website receives more than 1,800,000 hits per month and our Shopping Cart allows on-line product ordering 24 hours a day. Leveraging our database expertise, we continue to provide our Electronic Library free-of-charge to the tens of thousands of researchers worldwide that wish to keep pace with the microarray literature. eChem scientists were featured on NOVA’s evision show “Cracking the Code of Life” in 2001. As the fast-growing private biotechnology company in the United States, the company received the Rising Star Award from the City of Sunnyvale in 2002 and 2003, the Silicon Valley 50 Award from the San Jose Business Journal in 2003, and consecutive selection to the Inc. 500 List in 2002 and 2003 by Inc. magazine.
上海金畔生物科技有限公司
